PatientMatch — Privacy-first clinical trial discovery

229 trials

LymphomaRecruiting now

Enrolling now24

Nationwide

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Enterome

Ph 1/2·~11yr·4 sites in MA, MN, NY +1

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

WU-CART-007 Trial

Wugen, Inc.

Ph 2·~4yr·8 sites in CA, FL, MO +4

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Phase II Trial of Axicabtagene Ciloleucel with Radiation Therapy in Relapsed/Refractory Follicular Lymphoma

M.D. Anderson Cancer Center

Ph 2·~5yr·1 site in TX

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Phase II Trial of Loncastuximab Tesirine for Relapsed/Refractory Large B-cell Lymphoma After CAR T-cell Therapy

M.D. Anderson Cancer Center

Ph 2·~3yr·1 site in TX

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Center for International Blood and Marrow Transplant Research

Ph 2·~3yr·13 sites in AL, CA, FL +9

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

CTX112 Trial

CRISPR Therapeutics AG

Ph 1/2·~7yr·4 sites in KS, MO, TX +1

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Hoffmann-La Roche

Ph 1·~5yr·15 sites in CA, DC, FL +8

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study of AZD0486 for B-Cell Non-Hodgkin Lymphoma

AstraZeneca

Ph 1·~7yr·10 sites in FL, KY, NC +6

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

VIVUS LLC

Ph 2·~14mo·4 sites in AZ, CA, GA +1

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Janssen Research & Development, LLC

Ph 1/2·~6yr·14 sites in CA, CO, IA +8

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Turning Point Therapeutics, Inc.

Ph 1/2·~8yr·20 sites in CA, CO, FL +12

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

M.D. Anderson Cancer Center

Procedure·Ph 2·~4yr·1 site in TX

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of Lisocabtagene Maraleucel (Liso-cel) for Transplant-Ineligible PCNSL

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Ph 2·~3yr·30 sites in CA, CO, FL +10

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

Treeline Biosciences, Inc.

Ph 1·~4yr·4 sites in CA, MO, NY +1

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study to Compare Golcadomide and Rituximab vs Investigator's Choice in Follicular Lymphoma

Celgene

Ph 3·~5yr·31 sites in AK, AL, AR +14

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Genmab

Ph 2·~10yr·18 sites in AZ, CT, DE +10

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Grifols Therapeutics LLC

Ph 3·~4yr·7 sites in CA, FL, MD +3

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)

ADC Therapeutics S.A.

Ph 1·~4yr·1 site in CA

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Merck Sharp & Dohme LLC

Ph 3·~7yr·36 sites in AZ, CA, CO +18

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

University of Chicago

Ph 1/2·~2yr·2 sites in IL, NY

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

ABBA CORD Trial: dCBT with Abatacept for Graft vs. Host Disease Prevention

Leland Metheny

Procedure·Ph 2·~4yr·1 site in OH

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

ACE1831 Trial

Acepodia Biotech, Inc.

Ph 1·~5yr·5 sites in FL, GA, IN +2

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Baylor College of Medicine

Ph 1·~22yr·2 sites in TX

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

AlloSCT for Blood Disorders

Mitchell Cairo

Ph 2·~7yr·1 site in NY

Enrolling now

9q~2min

Check if I qualify View study